Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission.
Machova Polakova K, Zizkova H, Zuna J, Motlova E, Hovorkova L, Gottschalk A, Glauche I, Koblihova J, Pecherkova P, Klamova H, Stastna Markova M, Srbova D, Benesova A, Polivkova V, Jurcek T, Zackova D, Mayer J, Ernst T, Mahon FX, Saussele S, Roeder I, Cross NCP, Hochhaus A. Machova Polakova K, et al. Among authors: pecherkova p. Leukemia. 2020 Aug;34(8):2113-2124. doi: 10.1038/s41375-020-0882-1. Epub 2020 May 29. Leukemia. 2020. PMID: 32472084
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.
Jaruskova M, Curik N, Hercog R, Polivkova V, Motlova E, Benes V, Klamova H, Pecherkova P, Belohlavkova P, Vrbacky F, Machova Polakova K. Jaruskova M, et al. Among authors: pecherkova p. J Exp Clin Cancer Res. 2017 Apr 18;36(1):55. doi: 10.1186/s13046-017-0523-3. J Exp Clin Cancer Res. 2017. PMID: 28420426 Free PMC article.
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.
Srutova K, Curik N, Burda P, Savvulidi F, Silvestri G, Trotta R, Klamova H, Pecherkova P, Sovova Z, Koblihova J, Stopka T, Perrotti D, Polakova KM. Srutova K, et al. Among authors: pecherkova p. Haematologica. 2018 Dec;103(12):2016-2025. doi: 10.3324/haematol.2018.193086. Epub 2018 Jul 26. Haematologica. 2018. PMID: 30049824 Free PMC article.
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.
Kuželová K, Brodská B, Schetelig J, Röllig C, Ráčil Z, Walz JS, Helbig G, Fuchs O, Vraná M, Pecherková P, Šálek C, Mayer J. Kuželová K, et al. Among authors: pecherkova p. PLoS One. 2018 Dec 17;13(12):e0204290. doi: 10.1371/journal.pone.0204290. eCollection 2018. PLoS One. 2018. PMID: 30557403 Free PMC article. Clinical Trial.
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant.
Šálek C, Folber F, Froňková E, Pecherková P, Jelínková H, Hrabovský Š, Horáček JM, Cetkovský P, Mayer J, Trka J, Doubek M; Czech Leukemia Study Group - for Life (CELL). Šálek C, et al. Among authors: pecherkova p. Br J Haematol. 2022 Feb;196(3):706-710. doi: 10.1111/bjh.17966. Epub 2021 Nov 23. Br J Haematol. 2022. PMID: 34816424
Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT.
Šťastná-Marková M, Hamšíková E, Hainz P, Hubáček P, Kroutilová M, Kryštofová J, Ludvíková V, Musil J, Pecherková P, Saláková M, Šroller V, Vydra J, Němečková Š. Šťastná-Marková M, et al. Among authors: pecherkova p. Vaccines (Basel). 2021 Oct 22;9(11):1226. doi: 10.3390/vaccines9111226. Vaccines (Basel). 2021. PMID: 34835157 Free PMC article.
Distribution of HLA-DQB1 in Czech Patients with Central Hypersomnias.
Vrana M, Siffnerova V, Pecherkova P, Ratajova E, Sonka K. Vrana M, et al. Among authors: pecherkova p. Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):89-98. doi: 10.1007/s00005-016-0435-5. Epub 2017 Jan 12. Arch Immunol Ther Exp (Warsz). 2016. PMID: 28083611 Free article.
20 results